Cabaletta Bio
NASDAQ: CABARadnor, US · Founded 2017 · Delaware corporation · 199 employees on LinkedIn · 1 known investors
Cabaletta Bio is a clinical-stage biotechnology company developing engineered T cell therapies for patients with autoimmune diseases. Its CABA platform and lead CARTA program center on rese-cel, an investigational CD19-CAR T cell therapy being evaluated in trials across rheumatology, neurology, and dermatology.
Founders & leadership
Cabaletta Bio was founded in 2017 by Steven Nichtberger and Steven Nichtberger, MD.
SN
Steven NichtbergerCo-founder
SN
Steven Nichtberger, MDinCo-founder, Chairman, & CEOSteven Nichtberger, MD, is the founder, chairman, and founding CEO of Cabaletta Bio, a clinical-stage biotechnology company developing engineered T cell therapies for autoimmune diseases. His prior career spans pharmaceuticals, cellular therapy, and medical devices, including senior commercial and strategic leadership at Merck, CEO and President of Tengion, chairman of ControlRad Systems, and partner at GBF Advisors.
DG
Dan GeffkenExecutive
MS
Mark SimonNamed on SEC filing
AM
Anup MardaChief Financial Officer
Board
BD
Investors · 1
Reported raises · per SEC filings
Form D private placements$88.3M disclosed across 2 rounds · 2018–2019
▶$50MraisedJan 2019 · 16 investors · BiotechnologyRule 506(b)
▶$50MraisedJan 2019 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven NichtbergerExecutive Officer, Director
- Mark SimonDirector
- Brian DanielsDirector
- Dan GeffkenExecutive Officer
- Amount sold
- $50M
- Sales commissions
- $1.1M
- Placement agents
- Cowen and Company, LLC
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$38.3MraisedDec 2018 · 11 investors · BiotechnologyRule 506(b)
▶$38.3MraisedDec 2018 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark SimonDirector
- Steven NichtbergerExecutive Officer, Director
- Brian DanielsDirector
- Dan GeffkenExecutive Officer
- Amount sold
- $38.3M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Seeking Alpha43 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Robinhood39 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
StockTwits32 shared keywordsStocktwits is a social platform for investors and traders to share market news, discussions, sentiment polls, and live financial content. It aggregates breaking market news, equity coverage, and community discussions around individual stocks and crypto.
Companies competing with Cabaletta Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Cabaletta Bio do?
- Cabaletta Bio is a clinical-stage biotechnology company developing engineered T cell therapies for patients with autoimmune diseases. Its CABA platform and lead CARTA program center on rese-cel, an investigational CD19-CAR T cell therapy being evaluated in trials across rheumatology, neurology, and dermatology.
- Who founded Cabaletta Bio?
- Cabaletta Bio was founded by Steven Nichtberger, Steven Nichtberger, MD in 2017.
- Who are Cabaletta Bio's investors?
- Cabaletta Bio's investors include 5AM Ventures.
- How much funding has Cabaletta Bio raised?
- Cabaletta Bio has disclosed $88.3M raised across 2 rounds.
- Where is Cabaletta Bio headquartered?
- Cabaletta Bio is headquartered in Radnor, US.